$96.56
-2.40-2.43%
Last update: Oct 30, 4:00 PM
Spyre Therapeutics Inc (SYRE) Stock Price, Quote, News & History
SYRENASDAQ
U.S. stocks rose Tuesday: Dow +350 points, S&P 500 +0.86%. Lamb Weston jumped 12% on strong results; Arrivent plunged 58%.
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Other companies in Spyre Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Spyre Therapeutics has a consensus price target of $100.88.
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $96.45 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Spyre Therapeutics.
Spyre Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Spyre Therapeutics.
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes...
